摘要
目的观察疏血通注射液对高血压性脑出血的治疗效果。方法将84例高血压性脑出血患者随机分为试验组和对照组各42例,对照组予以常规治疗,试验组除常规治疗外,在入院第7天开始给予疏血通6 ml,1次/d静滴,共14 d,在入院第1天、第7天、第21天分别进行头颅CT,根据CT对血肿及血肿周围低密度区体积进行记录,同时采用美国国立卫生院神经功能缺损评分(Nationgnal Institutes of Health stroke scale,NIHSS)评价神经功能缺损程度,并评价疗效。结果试验组血肿周围水肿体积及血肿体积在第21天明显小于对照组,神经功能改善优于对照组,试验组临床有效率(69.0%)显著高于对照组(47.6%),试验组未见血肿扩大、再出血等严重不良反应。结论疏血通注射液治疗高血压性脑出血效果良好,且未见明显不良反应。
Objective To observe the clinical efficacy of Shuxuetong in the treatment of hypertensive intracerebral hemorrhage（ICH）.Methods 84 patients with hypertensive ICH were randomly divided into two groups： the study group and the control group,each with 42 cases.Patients in the control group received routine treatment,while those in the study group were treated by intravenous injection with 6 ml shuxuetong once per day for 14 days.At admission,the 7th day and 21th day,CT was performed with the volume of hematoma and perihematomal low density area recorded.NIHSS was used to evaluate defect of neurological function,and the curative effect and adverse reaction were evaluated.Results On the 21th day,NIHSS in the study group was better than that in the control group,and the volumes of perihematomal low density area and hematoma in the study group were significantly decreased than that in the control group.The effective rate was significantly higher in the study group（69.0%） than control group（47.6%）.The study group showed no obvious adverse reactions.Conclusion Shuxuetong was effective in the treatment of hypertensive intracerebral hemorrhage,with no obvious adverse reactions.
出处
《海南医学》
CAS
2012年第4期4-6,共3页
Hainan Medical Journal
关键词
疏血通
高血压性脑出血
血肿
血肿周围低密度区
Shuxuetong
Hypertensive intracerebral hemorrhage
Hematoma
Perihematomal low-density area
